ADHD
Feature
Tips for addressing uptick in mental health visits: Primary care providers collaborate, innovate
Clinical psychologist recommends primary care providers screen all adult patients for depression and anxiety.
Conference Coverage
Family placement better for deprived kids than institutions
“Being placed in a family reduced the symptoms of reactive attachment disorder to pretty much nonexistent,” said Dr. Kathryn Humphreys.
Savvy Psychopharmacology
High-dose stimulants for adult ADHD
Ms. H, age 30, presents to the outpatient clinic for a follow-up visit, where she reports difficulty paying attention to conversations, starting...
News from the FDA/CDC
FDA moves to curb misuse of ADHD meds
The boxed warning will also advise heath care professionals to monitor patients closely for signs and symptoms of misuse, abuse, and addiction.
From the Journals
Widespread prescribing of stimulants with other CNS-active meds
CNS-active drug classes included antidepressants, anxiolytics/sedatives/hypnotics, antipsychotics, opioids, anticonvulsants, and other...
From the Journals
Most children with ADHD are not receiving treatment
Girls (vs. boys) and children from families with higher incomes and higher education levels were among those less likely to get treatment.
From the Journals
Walnuts linked to improved attention, psychological maturity in teens
Clinicians should advise adolescents “to eat a handful of walnuts three times a week for the rest of their lives. They may have a healthier brain...
Evidence-Based Reviews
Adult ADHD: 6 studies of pharmacologic interventions
FIRST OF 2 PARTS
New evidence can help guide the use of stimulants, viloxazine, guanfacine, and brexpiprazole.
Pearls
Clonidine: Off-label uses in pediatric patients
Clonidine is a centrally acting alpha-2 agonist originally developed for treating hypertension.
Latest News
Once-daily stimulant for ADHD safe, effective at 1 year
The most common Treatment-emergent adverse events during the treatment phase were decreased appetite, upper respiratory tract infection,...
From the Journals
Once-daily stimulant for ADHD safe, effective at 1 year
Most treatment-emergent adverse events were mild to moderate,in a phase 3 study.